Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Return on Invested Capital (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Return on Invested Capital for 4 consecutive years, with 0.26% as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Return on Invested Capital changed N/A year-over-year to 0.26%, compared with a TTM value of 0.26% through Jun 2023, changed N/A, and an annual FY2022 reading of 0.29%, up 152.0% over the prior year.
  • Return on Invested Capital was 0.26% for Q2 2023 at Terns Pharmaceuticals, down from 0.25% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.34% in Q4 2020 and bottomed at 0.98% in Q1 2021.
  • Average Return on Invested Capital over 4 years is 0.29%, with a median of 0.26% recorded in 2023.
  • The sharpest move saw Return on Invested Capital plummeted -64bps in 2021, then rose 3bps in 2022.
  • Year by year, Return on Invested Capital stood at 0.34% in 2020, then plummeted by -190bps to 0.3% in 2021, then increased by 10bps to 0.27% in 2022, then increased by 4bps to 0.26% in 2023.
  • Business Quant data shows Return on Invested Capital for TERN at 0.26% in Q2 2023, 0.25% in Q1 2023, and 0.27% in Q4 2022.